TickerFactsScreenerDevelopers

Structure Therapeutics Inc. (GPCR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2022: $26.09M2023: $129.79M2024: $169.51M2025: $799.62M$799.62M
2022Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$799.62M+371.7%
2024$169.51M+30.6%
2023$129.79M+397.5%
2022$26.09M—